Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So this ticker bought out Medicago in Canada who is working on development of Coronavirus possible vaccine as reported by them March 12 2020. And this ticker MTZPY is being taken over by MTLHY? Little confusing because both tickers still trade as far as I can tell. So the question is which ticker is the one if the virus vaccine from Medicago becomes a winner. If you read Medicago also has a plant based production facility to manufacture the vaccine. I think everyone is a little confused as to the ticker and this is why they are not moving along with being OTC. Keep them on watch low volume trade history. So if the herd comes could rocket.
I would need a pullback on $NAK before entering right now. But true about being a zip code changer if entered at the right price. With the current administration they actually have a shot at getting it push thru the EPA gauntlet of misguided over-regulation.
I stay away from anything Google but I did check out on the TKO website. Seem the have more than just this ALS drug in their pipeline. It appears the approval may have surprised everyone based on the low volume trading for the last month. Could produce a Tsunami if it is well received by the market.
Japanese ticker: TYO:4508, paste it in Google finance. Tokyo market opens at 8:00 PM EST. Should be interesting. Huge market opportunity specially after all the attention from the ice bucket challenge.
PMP's and their producers garner serious attention after the lackluster response by old pharma to respond to the recent Ebola outbreak. All PMP will see an explosive rise in valuation. Especially considering big tobacco looms in the background putting serious investment dollars in the technology.
Mitsubishi Tanabe Pharma Corporation is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in two business segments. The Medical Supplies segment is engaged in the research, development, manufacture and sale of ethical pharmaceutical and non-prescription drugs. The Others segment is engaged in the manufacture, purchase and sale of chemical products, as well as the management of real estate. On September 18, 2013, together with Philip Morris Investments B.V., the Company acquired all shares of Canada-based pharmaceutical company Medicago Inc., and then made it become a 60%-owned consolidated subsidiary. On April 1, 2014, the Company transferred all shares of a Tochigi-based wholly owned subsidiary to CMIC Holdings Co., Ltd.
Company Contact
Headquarters: Yodoyabashi Square
2-6-18, Kitahama, Chuo-ku
541-8505 OSAKA-SHI
JPN
Web Address:
http://www.mt-pharma.co.jp